MM-103: Relationship Between Corneal Exam Findings, Best-Corrected Visual Acuity (BCVA), and Ocular Symptoms in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) Receiving Belantamab Mafodotin (GSK2857916; Belamaf)
Year: 2021
Type: conference-abstract
Institutions: National and Kapodistrian University of Athens, University of Maryland, Baltimore, University College London Hospitals NHS Foundation Trust, Navarre Institute of Health Research, Clinica Universidad de Navarra, University of Chicago Medical Center, Moorfields Eye Hospital NHS Foundation Trust, NIHR Moorfields Biomedical Research Centre, University College London, GlaxoSmithKline (United States), GlaxoSmithKline (Switzerland), Princess Margaret Cancer Centre
Language: English
Topic: Drug-Induced Ocular Toxicity
Subfield: Ophthalmology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3198367048